SCHEMBL19377494

SCHEMBL19377494

CC(NC(=O)Nc1ccc(S(=O)(=O)Cc2ccc3c(c2)CNC3)cc1)c1cc(N2CCOCC2)ccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.43
▸ HTT P42858 4/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ MCL1 Q07820 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ PIK3CA P42336 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ POLB P06746 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ GAA P10253 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ NAMPT P43490 2/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ MLNR O43193 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ NR1H4 Q96RI1 1/20 0.38
▸ GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377084 0.90 MAPT (0.43) MAPTHTTKMT2ALMNAMEN1
SCHEMBL24799991 0.88 MAPT (0.42) MAPTHTTKMT2ALMNAMEN1
SCHEMBL19384137 0.85 MLNR (0.39) KMT2AMEN1MLNRNPC1RAB9A
SCHEMBL19377297 0.85 GHSR (0.47) MAPTHTTKMT2ALMNAMEN1
SCHEMBL19377448 0.83 MLNR (0.40) LMNAALDH1A1NAMPTCYP2C9MLNR
SCHEMBL19377070 0.80 MLNR (0.39) MAPTKMT2ALMNAMEN1ALDH1A1
SCHEMBL19377071 0.80 MLNR (0.39) MAPTKMT2ALMNAMEN1ALDH1A1
SCHEMBL19377261 0.78 CA12 (0.49) ALDH1A1POLBNAMPTMLNRCYP2D6
SCHEMBL19377112 0.77 MLNR (0.47) LMNAALDH1A1MLNRCYP2D6
SCHEMBL19377245 0.77 MLNR (0.42) GAAMAPK1NAMPTCYP2C9MLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
WO-2017162390-A1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2017-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR MAPT 3586/4885HTT 696/4885KMT2A 3175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback